Familiar with both sides of the table, the developers麓 objectives and the regulators麓 perspective on biopharmaceutical drug development:
Just started as Sr.Clinical Program Leader at Boehringer Ingelheim, Global Dept. Biosimilars Business.
For more than 6 years Head of Immunopharmacology at Merck Serono and scientific/regulatory adviser for Merck Serono麓s initial Biosimilar projects.
Involved in numerous Merck Serono Due Diligence evaluations, providing independent view on risks, value and strategic fit of external opportunities.
Seasoned consultant at the FORUM Institute for Management: Sharing my expert knowledge with executives from innovator and biosimilars industry, as well...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
